Showing results (191-200 of 201) with videos related to

Sort By:
Pageof 21
Klinische Wochenschrift|January 1, 1988
Coronary thrombolysis in man with pro-urokinase: improved efficacy with low dose urokinaseW Kasper, T Meinertz, S Hohnloser, et al.
Cytokine & Growth Factor Reviews|August 19, 2007
Enhancement of intravesical delivery with Syn3 potentiates interferon-alpha2b gene therapy for superficial bladder cancerT L Nagabhushan, D C Maneval, W F Benedict, et al.
Bone Marrow Transplantation|November 25, 1998
High incidence of adeno- and polyomavirus-induced hemorrhagic cystitis in bone marrow allotransplantation for hematological malignancy following T cell depletion and cyclosporineR Childs, C Sanchez, H Engler, et al.
The American Journal of Medicine|June 1, 1992
Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissuesJ J Staub, B U Althaus, H Engler, et al.
Molecular Psychiatry|February 1, 2017
Selective increase of cerebrospinal fluid IL-6 during experimental systemic inflammation in humans: association with depressive symptomsH Engler, P Brendt, J Wischermann, et al.
Nature Biotechnology|November 2, 2001
Re-engineering adenovirus regulatory pathways to enhance oncolytic specificity and efficacyM Ramachandra, A Rahman, A Zou, et al.
Gene Therapy|June 13, 2001
Identification of polyamides that enhance adenovirus-mediated gene expression in the urotheliumR J Connor, H Engler, T Machemer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 1998
p53 gene therapy in a rat model of hepatocellular carcinoma: intra-arterial delivery of a recombinant adenovirusS C Anderson, D E Johnson, M P Harris, et al.
Journal of Clinical Microbiology|January 5, 2002
Immunochromatographic strip test for rapid detection of diphtheria toxin: description and multicenter evaluation in areas of low and high prevalence of diphtheriaK H Engler, A Efstratiou, D Norn, et al.
Cancer Gene Therapy|November 1, 2001
Interferon alpha2b gene delivery using adenoviral vector causes inhibition of tumor growth in xenograft models from a variety of cancersC M Iqbal Ahmed, D E Johnson, G W Demers, et al.
Pageof 21